Evidence map›Paper›PMID 32970873›Full record

ReviewJournal of leukocyte biology2021

Brief review on the roles of neutrophils in cancer development.

Wang Long, Jingjing Chen, Chen Gao, Zhi Lin, Xubiao Xie, Helong Dai

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. The role of B cells in cancer development.Frontiers in oncology · 2022
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wang LongDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Jingjing ChenDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Chen GaoDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhi LinDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Xubiao XieDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Helong DaiDepartment of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.ORCID 0000-0002-0696-3081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils, which are traditionally regarded as a hallmark of inflammation, are also a member of the intratumoral immune cells. The roles of neutrophils in cancer development are diverse and undefined. So far, they are known to be involved in tumor initiation and tumor cell proliferation and metastasis. They show heterogeneity in both phenotypes and functions during early versus late stage of cancer development. Because they are also associated with the clinical outcomes of various types of solid tumors, cancer treatments that target neutrophils might be highly effective. In this review, we briefly cover the latest findings on the multiple roles of neutrophils in cancer development and point out the future directions as well.

Indexed as

AnimalsCarcinogenesisCell CommunicationClinical Trials as TopicHumansNeoplasmsNeutrophilsTumor MicroenvironmentcancerheterogeneityMDSCneutrophilsneutrophil-to-lymphocyte ratio

Identifiers

PMID32970873
PMCPMC7891660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.